Advances in surgery in neonatal complicated congenital heart disease
10.3760/cma.j.cn112434-20201223-00551
- VernacularTitle:新生儿复杂性先天性心脏病外科治疗新进展
- Author:
Zijie ZHOU
1
;
Kai LUO
;
Jinghao ZHENG
Author Information
1. 上海交通大学医学院附属上海儿童医学中心心胸外科，上海 200127
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2022;38(5):310-315
- CountryChina
- Language:Chinese
-
Abstract:
With the research and summary of the cases, the surgical indications, surgical procedures, and reference values for material selection for the surgical treatment of neonatal complex congenital heart disease are further refined, and the diagnosis and treatment system is further standardized and completed. In order to increase the success rate of surgery, reduce postoperative mortality and postoperative complications, many researchers have proposed improved surgical procedures, some of which have become mature technologies. In addition, in recent years, the surgical age of newborns has gradually advanced and the surgical weight has gradually decreased. In particular, the increasing application of Hybrid therapy has enabled some critically ill, premature, and low birth weight children to survive smoothly to accept surgical correction. This article will review the recent advances in the surgical treatment of neonatal complicated congenital heart disease.
